SM

Sarah McMichael

Sr. Manager Product Development at Peptilogics

Sarah McMichael is an experienced professional in the biopharmaceutical industry, currently serving as Manager of CMC Development at Peptilogics since January 2022. Previously held positions include Manager of MSAT at Sigilon Therapeutics, Inc., and Supervisor of Aseptic Manufacturing at Iovance Biotherapeutics, Inc. At Charles River Laboratories, Sarah worked as a Supervisor and Team Leader, overseeing a team in developing procedures for mammalian cell banks and vaccines. Early career roles include Business Process Manager at Heraeus and various positions during academic years at Juniata College, including facilities and sales roles. Sarah earned a Bachelor of Science in Biology from Juniata College, where notable achievements include being part of the NCAA DIII National Runner-up volleyball team.

Location

Philadelphia, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


P

Peptilogics

Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.


Industries

Employees

11-50

Links